These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 31428102

  • 1. Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis.
    DiSano KD, Royce DB, Gilli F, Pachner AR.
    Front Immunol; 2019; 10():1821. PubMed ID: 31428102
    [Abstract] [Full Text] [Related]

  • 2. Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis.
    DiSano KD, Linzey MR, Royce DB, Pachner AR, Gilli F.
    J Neuroinflammation; 2019 May 22; 16(1):109. PubMed ID: 31118079
    [Abstract] [Full Text] [Related]

  • 3. The immune response in the CNS in Theiler's virus induced demyelinating disease switches from an early adaptive response to a chronic innate-like response.
    Gilli F, Li L, Pachner AR.
    J Neurovirol; 2016 Feb 22; 22(1):66-79. PubMed ID: 26260496
    [Abstract] [Full Text] [Related]

  • 4. Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.
    Pachner AR, Brady J, Narayan K.
    J Neuroimmunol; 2007 Oct 22; 190(1-2):112-20. PubMed ID: 17919740
    [Abstract] [Full Text] [Related]

  • 5. Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.
    Atkinson JR, Bergmann CC.
    J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28931676
    [Abstract] [Full Text] [Related]

  • 6. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.
    Richards MH, Getts MT, Podojil JR, Jin YH, Kim BS, Miller SD.
    J Autoimmun; 2011 Mar 01; 36(2):142-54. PubMed ID: 21273044
    [Abstract] [Full Text] [Related]

  • 7. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease.
    Duncan DS, Miller SD.
    PLoS One; 2011 Apr 08; 6(4):e18548. PubMed ID: 21494618
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of B-cell depletion in the Theiler's model of multiple sclerosis.
    Gilli F, Li L, Campbell SJ, Anthony DC, Pachner AR.
    J Neurol Sci; 2015 Dec 15; 359(1-2):40-7. PubMed ID: 26671084
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IFNγ influences type I interferon response and susceptibility to Theiler's virus-induced demyelinating disease.
    Bowen JL, Olson JK.
    Viral Immunol; 2013 Aug 15; 26(4):223-38. PubMed ID: 23829778
    [Abstract] [Full Text] [Related]

  • 12. Immune mechanisms of Theiler's virus-induced demyelination.
    Kim BS, Palna JP.
    Exp Mol Med; 1999 Sep 30; 31(3):115-21. PubMed ID: 10551258
    [No Abstract] [Full Text] [Related]

  • 13. Deficient Natural Killer Dendritic Cell Responses Underlay the Induction of Theiler's Virus-Induced Autoimmunity.
    Chastain EM, Getts DR, Miller SD.
    mBio; 2015 Aug 04; 6(4):e01175. PubMed ID: 26242630
    [Abstract] [Full Text] [Related]

  • 14. The TIM-3 pathway ameliorates Theiler's murine encephalomyelitis virus-induced demyelinating disease.
    Kaneyama T, Tomiki H, Tsugane S, Inaba Y, Ichikawa M, Akiba H, Yagita H, Kim BS, Koh CS.
    Int Immunol; 2014 Jul 04; 26(7):369-81. PubMed ID: 24486565
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction.
    Karpus WJ, Pope JG, Peterson JD, Dal Canto MC, Miller SD.
    J Immunol; 1995 Jul 15; 155(2):947-57. PubMed ID: 7608570
    [Abstract] [Full Text] [Related]

  • 16. CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.
    Neville KL, Dal Canto MC, Bluestone JA, Miller SD.
    J Virol; 2000 Sep 15; 74(18):8349-57. PubMed ID: 10954534
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dynamics of Virus-Specific Memory B Cells and Plasmablasts following Viral Infection of the Central Nervous System.
    Atkinson JR, Hwang M, Reyes-Rodriguez A, Bergmann CC.
    J Virol; 2019 Jan 15; 93(2):. PubMed ID: 30333176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.